Kymera Therapeutics (KYMR) Accounts Payables (2019 - 2026)
Kymera Therapeutics (KYMR) reported Accounts Payables of $8.92 million for Q2 2026, up 54.3% from $5.78 million a year earlier but down 30.5% from the prior quarter.
Powered by 
Analysis
Kymera Therapeutics (KYMR) Accounts Payables (2019 - 2026) Analysis & Trends
At the end of FY2025, Kymera Therapeutics posted Accounts Payables of $4.02 million, down 33.0% from FY2024.
- Accounts Payables has a five-year compound annual growth rate of -1.7% (FY2020 to FY2025).
- By year, Accounts Payables came in at $5.99 million in FY2024 (-15.3%), $7.08 million in FY2023 (+63.2%), $4.34 million in FY2022 (+8.2%) and $4.01 million in FY2021 (-8.3%).
- Five-year quarterly Accounts Payables spans a low of $2.37 million in Q2 2022 and a high of $12.84 million in Q1 2026.
- Year over year, Accounts Payables gained in four of the last eight quarters, with growth averaging 10.7%.
- The high point for year-over-year Accounts Payables in five years was Q1 2023 (growth of 152.6%); the low point was Q2 2022 (a decline of 71.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $12.84 million (Q1 2026), $4.02 million (Q4 2025) and $5.51 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 9.22 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 3.83 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.58 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Kymera Therapeutics | 9.25 Bn | 6.56 Bn | - | 8.92 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.92 Mn |
| Mar 31, 2026 | 12.84 Mn |
| Dec 31, 2025 | 4.02 Mn |
| Sep 30, 2025 | 5.51 Mn |
| Jun 30, 2025 | 5.78 Mn |
| Mar 31, 2025 | 10.26 Mn |
| Dec 31, 2024 | 5.99 Mn |
| Sep 30, 2024 | 6.49 Mn |
| Jun 30, 2024 | 6.51 Mn |
| Mar 31, 2024 | 6.81 Mn |
| Dec 31, 2023 | 7.08 Mn |
| Sep 30, 2023 | 4.98 Mn |
| Jun 30, 2023 | 3.75 Mn |
| Mar 31, 2023 | 6.48 Mn |
| Dec 31, 2022 | 4.34 Mn |
| Sep 30, 2022 | 6.33 Mn |
| Jun 30, 2022 | 2.37 Mn |
| Mar 31, 2022 | 2.57 Mn |
| Dec 31, 2021 | 4.01 Mn |
| Sep 30, 2021 | 5.03 Mn |
API Access
Kymera Therapeutics Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=KYMR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "KYMR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=KYMR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();